Study on Pharmacokinetics Compound Niacin Extended-release Tablets in Beagle Dogs

Niu Huaying,Liu Bin,Kong Yumei,Liu Bingmi,Meng Fanrui
DOI: https://doi.org/10.3969/j.issn.1006-4931.2006.20.006
2006-01-01
Abstract:Objective To study the pharmacokinetics of compound niacin extended-release tablets in beagle dogs and bioequivalence.Methods A single oral dose of 500 mg was given according to a crossover design.The niacin concentrations in plasma were determined by RP-HPLC.Results In the single dose of 500 mg experiment tablets the AUC,Cmax,Tmax and t1/2 of the subject were(292.6±35.8)μg·h/mL,(69.2±10.2)μg/mL,(3.3±0.3)h,(2.1±0.3)h.Conclusion The two pharmaceutical preparations had marked differences in Cmax,Tmax and AUC(P < 0.05).The relative bioavailability was(99.5±17.0)%.
What problem does this paper attempt to address?